Breaking: Growth Surge in Intravenous Immunoglobulin (IVIG) Therapy Market
The United States is witnessing a substantial uptick in the Intravenous Immunoglobulin (IVIG) therapy market, poised to reach USD 17.02 billion by 2035. This surge is propelled by an impressive compound annual growth rate (CAGR) of 5.86%. Among the primary factors fueling this growth is the rising prevalence of autoimmune diseases, prompting greater demand for immunoglobulin products....
0 Comentários 0 Compartilhamentos 15 Visualizações 0 Anterior